Articles From: Dot Hill Reports Third Quarter 2014 Results to Heron Therapeutics Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights


Third Quarter Revenue and EPS within Guidance Projecting 25% non-GAAP revenue and over 250% non-GAAP EPS sequential growth at fourth quarter guidance midpoint LONGMONT, Colo., Nov.
Sign-up for Dot Hill Reports Third Quarter 2014 Results investment picks
BAUDETTE, Minn.
Sign-up for ANI Pharmaceuticals Announces the Launch of Methazolamide Tablets USP investment picks
SOLANA BEACH, Calif., Nov.
Sign-up for Evoke Pharma Schedules Webcast and Conference Call for Third Quarter 2014 Financial Results investment picks
RADNOR, Pa., Nov.
Sign-up for Actua Announces Third Quarter 2014 Financial Results investment picks
CAMBRIDGE, Mass., Nov.
Sign-up for Momenta Pharmaceuticals to Webcast Presentation at Three Upcoming Investor Conferences investment picks
http://media.marketwire.com/attachments/201409/276763_pfs.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156300&ProfileId=051205&sourceType=1 ALLEN, TX --
Sign-up for PFSweb Sets Third Quarter Conference Call for Wednesday, November 12, 2014 at 11:00 a.m. ET investment picks
DALLAS, Nov.
Sign-up for Speed Commerce Reports Fiscal Second Quarter 2015 Results investment picks
http://media.marketwire.com/attachments/200903/435497_coremarklogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156711&ProfileId=051205&sourceType=1 SOUTH SAN FRANCISCO, CA --
Sign-up for Core-Mark Announces Third Quarter 2014 Financial Results, Increases Dividend investment picks
Bear State Financial, Inc. (“Bear State”) (NASDAQ: BSF), today reported earnings of $22.7 million and earnings per diluted common share of $0.75 in the third quarter of 2014, compared to earnings of $143,000 or $0.01 per diluted common share in the third quarter of 2013, a 15,757% increase.
Sign-up for Bear State Financial, Inc.: Record Third Quarter 2014 Results Show Substantial Earnings and Book Value Accretion From Recent Merger investment picks
DUBLIN, Calif., Nov.
Sign-up for Ross Stores Announces Third Quarter 2014 Earnings Release and Conference Call investment picks
http://media.marketwire.com/attachments/201305/153545_PRLibertyLogo2c.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1156941&ProfileId=051205&sourceType=1 VIRGINIA BEACH, VA --
Sign-up for Liberty Tax Service Creates New, Hispanic-Focused Brand -- SiempreTax+ investment picks
Orbitz Worldwide (OWW) reported on Thursday a third-quarter profit of $9 million, or 8 cents a share, down from $13 million, or 11 cents a share, in the year-earlier period.
Sign-up for Orbitz profit falls short of estimates investment picks
PharMerica Corporation (NYSE:PMC), a national provider of institutional, specialty home infusion, hospital and oncology pharmacy services, today reported its financial results for the third quarter and nine months ended September 30, 2014.
Sign-up for PharMerica Reports Third Quarter 2014 Results investment picks
GFI Shareholders Urged to Tender Their Shares NEW YORK , Nov.
Sign-up for BGC's All-Cash Tender Clearly Represents Superior Value For GFI Shareholders investment picks
Sparton Corporation (NYSE:SPA) has announced the completed transition of the Aubrey Group brand to Sparton.
Sign-up for Aubrey Group Brand Fully Transitions to Sparton Corporation investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today disclosed a development program for a P/neurokinin-1 (NK 1 ) receptor antagonist, which is used in the prevention of both acute- and delayed-onset chemotherapy induced nausea and vomiting (CINV). NK 1 receptor antagonists are administered in combination with a 5-HT 3 receptor antagonist for the prevention of CINV.
Sign-up for Heron Therapeutics Discloses New Proprietary Intravenous Formulation of NK-1 Receptor Antagonist for Prevention of CINV investment picks
QAD Inc. (NASDAQ:QADA) (NASDAQ:QADB), a leading provider of enterprise software and services, is pleased to share the success of its longstanding relationship with Lear Corporation, a leading global supplier of automotive seating and electrical distribution systems.
Sign-up for QAD and Lear Corporation Share Success of 20-year Partnership investment picks
Guided Therapeutics, Inc. (OTCQB: GTHP), developer of a rapid and painless testing platform that uses biophotonics for the early detection of disease, today announced that it is scheduled to report financial results for its third quarter ended September 30, 2014 on Thursday, November 13, 2014, after the market closes.
Sign-up for Guided Therapeutics to Report Third Quarter 2014 Results and Hold Conference Call investment picks
Perficient, Inc. (NASDAQ: PRFT) (“Perficient”), a leading information technology and management consulting firm serving Global 2000® and other large enterprise customers throughout North America, today reported its financial results for the quarter ended September 30, 2014.
Sign-up for Perficient Reports Third Quarter 2014 Results investment picks
HIGHLIGHTS - Third quarter adjusted EPS increased 8.5% from prior year to $0.89 in 2014 - Total net sales increased 40.3%, driven by acquisitions and volume/mix - North American Retail Grocery volume/mix grew 4.7% in the third quarter - Full production of 2.0 compatible single serve hot beverages began at the end of October - Company tightens full year adjusted EPS guidance to $3.60-$3.70, reflecting higher share count OAK BROOK, Ill.
Sign-up for TreeHouse Foods, Inc. Reports Third Quarter 2014 Results investment picks
Heron Therapeutics, Inc. (NASDAQ:HRTX), a biotechnology company, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress.
Sign-up for Heron Therapeutics Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: Dot Hill Reports Third Quarter 2014 Results to Heron Therapeutics Announces Third Quarter and Year-to-Date 2014 Financial Results and Corporate Highlights
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent